Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

FMC Peroxygens Go To Private Equity

by Michael McCoy
December 23, 2013 | A version of this story appeared in Volume 91, Issue 51

FMC Corp. has agreed to sell its per­oxygens business to One Equity Partners, the private investment arm of JPMorgan Chase, in a transaction the two firms value at about $200 million. FMC announced in April that it would divest the business as part of a corporate reorganization. The investment firm Jefferies estimated at the time that the business could be worth as much as $800 million. It has about $350 million in annual sales of hydrogen peroxide and persulfate chemicals.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.